This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lucas, C. Articles by Sykes, J. V Search for Related Content PubMed PubMed Citation Articles by Lucas, C. Articles by Sykes, J. V Social Bookmarking                         What's this?

Contribution of a liaison clinical pharmacist to an inpatient palliative care unit

HIV/AIDS Unit

Paul A Glare

Central Sydney Palliative Care Service, Royal Prince Alfred Hospital, Sydney

Joanna V Sykes

Central Sydney Palliative Care Service, Royal Prince Alfred Hospital, Sydney

The impact on patient care of interventions made by a liaison clinical pharmacist visiting a busy inpatient palliative care unit were evaluated using a validated six-point scoring system. Interventions made in 13% of patients could improve patient care, save money or both, but rarely involved the drugs that are commonly used for symptom control in patients with terminal cancer. Advice to rationalize inappropriate drug regimens (53%) was the commonest intervention, followed by warnings about drug interactions (24%) and advice about therapeutic drug monitoring (8%). The interventions were evaluated by the pharmacist, a palliative medicine registrar and two independent doctors, confirming that the pharmacist was valid and accurate in assessing her own work. Although more than 60% of interventions could significantly improve patient care, compliance by medical and nursing staff with advice was only 55%, reflecting possible tensions between palliative and general hospital medicine. This survey emphasizes the role of liaison clinical pharmacists in palliative care, the need for much more critical appraisal of prescribing practices and the utility of ranking pharmacist interventions as a quality assurance and educational tool. In particular, providing palliative care for patients with advanced acquired immunodeficiency syndrome (AIDS) is enhanced when a pharmacist with a specialist knowledge of AIDS therapeutics is available.

Key Words: palliative care • pharmacy service • hospital • terminal care • drug interactions • acquired immunodeficiency syndrome • hospices

Palliative Medicine, Vol. 11, No. 3, 209-216 (1997)
DOI: 10.1177/026921639701100305


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Lee and M. L. McPherson Outcomes of recommendations by hospice pharmacists Am. J. Health Syst. Pharm., November 15, 2006; 63(22): 2235 - 2239. [Abstract] [Full Text] [PDF]

				R. Harding, P. Easterbrook, I. J Higginson, D. Karus, V. H Raveis, and K. Marconi Access and equity in HIV/AIDS palliative care: a review of the evidence and responses Palliative Medicine, April 1, 2005; 19(3): 251 - 258. [Abstract] [PDF]

				R Harding, D Karus, P Easterbrook, V H Raveis, I J Higginson, and K Marconi Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence Sex Transm Inf, February 1, 2005; 81(1): 5 - 14. [Abstract] [Full Text] [PDF]

				C. M. Herndon, K. Jackson II, D. S. Fike, and T. Woods End-of-life care education in United States pharmacy schools American Journal of Hospice and Palliative Medicine, September 1, 2003; 20(5): 340 - 344. [Abstract] [PDF]

				D S Needham, I C K Wong, and P D Campion Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care Palliative Medicine, April 1, 2002; 16(3): 219 - 225. [Abstract] [PDF]

				C. M. Herndon, D. S. Fike, A. C. Anderson, and E. J. Dole Pharmacy student training in United States hospices American Journal of Hospice and Palliative Medicine, May 1, 2001; 18(3): 181 - 186. [Abstract] [PDF]